CrowdfundedWealth

Saba Capital's Nov 13, 2026 Letter on Bluerock BPRE: 43% Below NAV, 5.12% Stake, 2027 Vote

ResearchBy Jorge19 min read8 SEC filings cited

Some links pay us a referral fee; each one says so. Disclosure

Quick answer

On November 13, 2026 Saba Capital Management, L.P. filed new soliciting material (Form DFAN14A, accession 0000902664-26-004538) on Bluerock Private Real Estate Fund (NYSE: BPRE, CIK 1551047). It says the fund trades 43% below its net asset value, based on a $12.47 close and a $21.92 reported NAV on November 2, 2026, and for the first time asks the Board to appoint “a more capable manager”, naming Cohen & Steers “as an example only”. Saba still reports 7,322,660 shares, 5.12% of the fund, bought for about $107.8 million (average $14.73), and says it will file a definitive proxy statement for the 2027 annual meeting. What Saba's letter does not mention: between September 21 and October 27, 2026 a trustee's holding entity bought 3,068,976 shares on 28 purchase lines in Forms 4 at an average $12.63, about $38.8 million, or 2.15% of the shares outstanding (our arithmetic). The fund itself has filed no response on EDGAR since its August 7, 2026 8-K. The dates that matter run into 2027: shareholder proposals by March 2, 2027 and nominations between April 6 and May 6, 2027. This is analysis of public documents, not investment, legal or tax advice.

Key takeaways

  • The November 13, 2026 filing is a cover page plus four images. The text is in the images, not in the filing's HTML, so a text search of EDGAR finds almost nothing in it. Page 1 says BPRE “currently trades 43% below its net asset value”, based on the October 30, 2026 close; page 3 uses $12.47 and $21.92 as of November 2, 2026. We get 43.1% from those two figures (our arithmetic).
  • New in this letter: a named alternative. Page 3 asks shareholders to “Terminate Bluerock” and the Board to appoint “a more capable manager, such as Cohen & Steers”. Saba says it has no agreement with Cohen & Steers and that the appointment would need the Board and a shareholder vote. The September 25, 2026 letter named no replacement.
  • Saba's stake has not moved. The 13D/A of August 27, 2026 and the disclaimer of November 13, 2026 both say 7,322,660 shares, 5.12% of 143,044,372. Its last purchases were 51,432, 53,160 and 16,686 shares on July 31, August 3 and August 4, 2026. At $12.47 the position is about 15.3% under its $14.73 average cost, roughly $16.5 million (our arithmetic).
  • A trustee's holding entity bought 3,068,976 shares on 28 purchase lines from September 21 to October 27, 2026 at an average $12.63, about $38.8 million, 2.15% of 143,044,372 shares (our arithmetic on the Forms 4 and 4/A). The Chief Investment Officer bought 37,965 shares from September 14 to October 13, 2026 and the President 10,340 from September 28 to October 21, 2026.
  • Saba's fee claim is stated before the waiver. Its 1.70% is the 1.50% management fee plus the 0.20% administrative fee that started in July 2026; the 8-K of July 2, 2026 says the Adviser waives about 53% of the administrative fee on the July 1, 2026 portfolio. The fee is paid to the fund's own Adviser, and the semi-annual report shows $26,349,698 of advisory fees in the six months to March 31, 2026.
  • The vote arithmetic: at the August 4, 2026 meeting 10,709,923 and 10,785,196 shares were withheld from the two trustees up for election (9.86% and 9.93% of votes cast, 7.49% and 7.54% of all shares), more than Saba's whole position. A simple majority of the 143,044,372 shares is 71,522,186 shares, and Saba's 7,322,660 is 10.2% of that (our arithmetic).
  • Dates: the cap on any holder owning more than 4.9% of the fund rises to 9.9% after December 16, 2026; Rule 14a-8 proposals for the 2027 meeting are due March 2, 2027; nominations can be delivered from April 6 to May 6, 2027. Two Class II trustee seats expire at that meeting.

CSV · 114 rows

Saba Capital and Bluerock Private Real Estate Fund (BPRE): the November 13, 2026 filing, Saba's stake, the fund's own filings and every insider purchase

114 rows from the DFAN14A letters of November 13 and September 25, 2026, Saba's Schedule 13D/A, the fund's 8-Ks, proxy statement and semi-annual report, and each insider purchase line from the Forms 4. SEC accession on each row; our arithmetic is labelled in the note column.

Our Bluerock Private Real Estate Fund review already carries the listing day, the series of Saba's open-market purchases from its 13D filings, the books-and-records demand and the September 2026 launch of FireBluerock.com. This page does not repeat that. It reads what is new since then: the November 13 letter, what has changed in Saba's position (nothing), what the people who run the fund have done with their own money (a lot), and the calendar that decides when shareholders get a vote. The contest is still at the soliciting-material stage: no definitive proxy statement for the 2027 meeting had been filed by either side as of November 16, 2026.

What Saba filed on November 13, 2026

The filing is a Schedule 14A cover page marked “Soliciting Material Under Rule 14a-12”, filed by Saba Capital Management, L.P. and its principal, and four images. Two are letters to shareholders and two are the legal disclaimer. Saba has now filed four pieces of soliciting material on BPRE: two on September 16, one on September 25 and this one.

ItemSeptember 25, 2026 letterNovember 13, 2026 letter
Discount to NAV47% (Bloomberg, September 21, 2026)43% (closing price and reported NAV, October 30, 2026; $12.47 and $21.92 on November 2, 2026)
Reported NAV cited$24.36 last published value before listing$21.92 on November 2, 2026
AskVisit FireBluerock.com; “an important vote” in 2027“Terminate Bluerock”; Board to appoint “a more capable manager”, Cohen & Steers named as an example
Fee pointNot raised0.20% administrative fee on top of 1.50%, “at least 1.70%”, approved by the Board without a shareholder vote
Peer comparisonNoneCohen & Steers real estate closed-end funds at a 9% discount on November 2, 2026, 5.3% average since the December 2025 listing; BPRE 37.5% average
Saba shares7,322,6607,322,660

Two further points about the document itself. First, the reported NAV fell from $24.36 before listing to $21.92 on November 2, 2026, 10.0% (our arithmetic on Saba's two figures), while the semi-annual report shows $23.65 at March 31, 2026, so the further fall since March is 7.3% (our arithmetic). Second, the footnotes say the figures come from Saba's own calculations, Bloomberg and the fund's filings; the NAV and price are Saba's citation, not a fund document read on November 16, 2026.

Checking Saba's numbers against the fund's own filings

A soliciting letter is advocacy. These are the checkable claims in it and what the fund's filings say.

Saba saysWhat the fund's filing saysNote
Management fee 1.50%Semi-annual report: the Advisor receives monthly fees at an annual rate of 1.50% of average daily net assets; $26,349,698 earned in the six months to March 31, 2026Confirmed. Twice that is $52.7 million a year (our arithmetic), before the new fee
A second fee of 0.20% since July 20268-K, July 2, 2026: Administrative Services Agreement with the Adviser, 0.20% a year of average managed assets, paid monthly from July 1, 2026Confirmed. Managed assets are net assets plus borrowings plus preferred, so the base is larger than net assets
Total fee “at least 1.70%”Same 8-K: the Adviser waives the part of the fee on managed assets in Institutional Investment Funds, about 53% on the July 1, 2026 portfolioSaba's footnote says “before Bluerock's voluntary partial waiver”. After the waiver the second fee is about 0.09% (our arithmetic: 0.20% x 47%)
Board approved the fee without a shareholder voteThe 8-K describes an agreement entered into by the fund and says amendments need the Board, including a majority of the independent trustees. It does not mention a shareholder voteConsistent with the 8-K text; the 8-K does not say either way whether a vote was needed
Shareholders can end the manager contract on 60 days' notice by majority vote8-K, July 2, 2026, for the Administrative Services Agreement: may be terminated on 60 days' written notice by the independent trustees, by “a majority of the outstanding voting securities of the Fund”, or by the AdviserThe 8-K gives these terms for the administrative agreement. The investment management agreement is not in the filings we read
Listing was pitched with $8 million to $10 million a year of savingsCites the July 2025 proxy statementNot in the 2026 proxy statement we read; not checked

For scale: net assets were $3,332,609,890.83 at June 30, 2026 (N-PORT-P, acc. 0001049169-26-002153) over the 143,044,372 shares that the fund's Form 8-K of August 7, 2026 counts as entitled to vote at the June 15, 2026 record date (acc. 0001398344-26-013771), about $23.30 a share (our arithmetic; the two dates are 15 days apart). The fund also had $495,000,000 of borrowings, about 14.9% of net assets (our arithmetic).

The largest single exposure is IQHQ, Inc.: at June 30, 2026 the fund's N-PORT-P lists positions in it (shares, preferred stock, loans and warrants) worth about $787.6 million, 23.6% of net assets (acc. 0001049169-26-002153), and the fund's proxy statement of June 30, 2026 says that the officer it describes as “Chief Investment Officer for Bluerock and certain of its affiliates” “also currently serves as Co-Chairman of IQHQ, Inc.” (acc. 0002071844-26-000752).

The Cohen & Steers comparison

Saba's page 3 compares BPRE with four Cohen & Steers real estate closed-end funds and says the problem “is the manager, not real estate”. Its footnote carries the caveat that matters: those funds “hold mainly listed real estate securities; BPRE's portfolio differs”. BPRE's portfolio is institutional private real estate funds and direct property, valued by appraisal, which is what the fund's own listing repriced. The $19.92 in the letter is labelled “Illustration only, not a prediction”: $21.92 less the 9.13% average discount of the four funds on November 2, 2026. Read it as a statement of the gap Saba wants closed, not as a value.

What the fund's insiders bought

This is the part of the story no letter covers, because it sits in Forms 4. Between September 14 and October 27, 2026 three people with roles at the fund filed Code P purchases in BPRE shares.

Week of purchases (2026)Shares bought by the trustee's entityAverage priceCumulative shares
September 21 to 25480,770$12.28480,770
September 28 to October 2601,010$12.591,081,780
October 5 to 9744,807$13.011,826,587
October 12 to 16621,837$12.702,448,424
October 19 to 23441,875$12.382,890,299
October 26 to 27178,677$12.483,068,976

The weekly figures are our sums of the Form 4 lines. The filer is a trustee on the Board, buying through an entity the trustee controls, and the first Form 4 lines were filed with Code J on September 23 and 25, 2026 and re-filed with Code P in two amendments (Form 4/A) on September 29, 2026. The Form 4 of October 28, 2026 reports 3,069,420 shares owned after the last purchase. In all, 28 purchase lines, 3,068,976 shares, about $38.8 million at a weighted $12.63, 2.15% of the 143,044,372 shares (our arithmetic). We do not name the person; the filings are linked in the CSV.

Buyer (by role)Dates of purchasesSharesAverage priceOwned after last purchase
Trustee, through a holding entitySeptember 21 to October 27, 20263,068,976$12.633,069,420 (indirect)
Chief Investment Officer, also a trusteeSeptember 14 to October 13, 202637,965$12.1042,395 (direct)
PresidentSeptember 28 to October 21, 202610,340$12.5019,232 (direct)

The timing is a fact, not a motive. The Chief Investment Officer's first purchases, 20,745 shares on September 14, 2026, came the day before Saba launched FireBluerock.com, and the trustee entity's purchases began a week after. The filings give no reason for any of them. Saba's letter does not mention them. Next to Saba's, the position looks like this:

HolderSharesShare of 143,044,372Average costAt $12.47
Saba Capital (13D/A, August 27, 2026)7,322,6605.12%$14.73About 15.3% below cost
Trustee's holding entity (Forms 4)3,069,4202.15%$12.63 on the purchasesAbout 1.3% below cost on the purchases

All of it in our arithmetic from the filings; the $12.47 is Saba's November 2, 2026 close. Both large buyers are, at that price, under water, and the trustee's entity bought at lower prices than Saba on average.

The calendar: what decides when shareholders get a vote

The proxy statement the fund filed on June 30, 2026 sets the dates. Nothing in it is about Saba; it is the ordinary calendar of the 2027 meeting.

DateWhat happensSource
December 16, 2026The cap on any person owning more than 4.9% of the fund ends and the 9.9% cap appliesDEF 14A, June 30, 2026
March 2, 2027Deadline for Rule 14a-8 proposals for the 2027 annual meetingDEF 14A, June 30, 2026
April 6, 2027 to May 6, 2027Window to deliver shareholder nominations and other proposals for the 2027 meetingDEF 14A, June 30, 2026
2027 annual meetingTwo Class II trustee seats expire: one interested trustee and one independent trusteeDEF 14A, June 30, 2026

Three things follow from these dates and the August vote.

  1. The 4.9% cap and Saba's 5.12%. The fund's declaration limits any person to 4.9% until December 16, 2026 and says the limits do not apply retroactively to shares acquired before the listing. Saba bought after the listing and reports 5.12%. The filings we read do not say whether the Board granted an exemption, and Saba's 13D/A does not mention the cap. The proxy statement also describes Delaware control-share provisions that limit voting above thresholds that start at 10%; Saba is below that.
  2. The size of the vote. In August 2026, 108,605,132 shares were voted for the first trustee, 75.9% of all shares (our arithmetic). A simple majority of all shares is 71,522,186. The ASA's own wording, “a majority of the outstanding voting securities of the Fund”, is the standard Saba is citing for the manager contract. Saba's 7,322,660 is 10.2% of the way to a simple majority; the shares withheld from the trustees in August, 10,709,923 and 10,785,196, are each larger than Saba's whole position.
  3. What Saba has said it will propose. Its Schedule 13D/A says: “At the 2027 Annual Meeting, Saba Capital intends to submit a shareholder proposal to terminate the Issuer's investment manager, seek Board change and conduct a proxy solicitation.” The Board would then need an agreement with any new manager and shareholder approval, as Saba's own footnote says.

We make no prediction about the vote.

What has not happened

  • No fund response on EDGAR. In the filing list we read on November 16, 2026 the fund's own filings since the August 7, 2026 8-K are a Form N-PORT on August 28, 2026 and the Forms 4 of its insiders. There is no DEFA14A, no 8-K answering Saba and no soliciting material from the fund.
  • No definitive proxy statement from Saba. Its letters say it intends to file one for the 2027 meeting. The 2027 meeting date has not been set in any filing we read.
  • No change in Saba's share count since the August 27, 2026 13D/A: the disclaimers of September 25 and November 13, 2026 give the same 7,322,660. Saba's September 25 letter says that “closing that gap is simple, as we have shown in dozens of past examples”; we have not checked those other contests for this page, and our page on Cox Capital and Saba's tender offers covers what the two did at other non-traded funds.
  • The December 2025 buyback. The 1% open-market authorization is covered in our review; no newer fund filing reports its use.

What a reader can do with this

This is analysis of public documents, not investment, legal or tax advice.

  • Know which number is whose. The 43% discount and the $21.92 NAV in the letter are Saba's citations. The fund's own NAV is in its filings and on its daily NAV; check the figure against the fund's page before you rely on it.
  • Separate advocacy from filings. Saba's fee total of $463.8 million since 2012 and the $42,071 loss on $100,000 are Saba's calculations from the fund's Forms N-2 and a Bloomberg price series; the footnotes say so and we did not rebuild them.
  • Read the Forms 4 as well as the letters. A trustee's entity buying about 3.07 million shares is public and ongoing; any new purchase would appear as a Form 4 on EDGAR under the fund's CIK 1551047.
  • If you hold shares, note the dates. The nomination window and the Rule 14a-8 deadline are in the fund's June 30, 2026 proxy statement. A shareholder who wants to submit a proposal or nomination should read the Declaration of Trust and the By-Laws for the exact requirements.
  • Selling is a market decision. The shares trade on the NYSE at a price Saba puts 43% below NAV. If you are weighing a sale, the tax on a loss against your cost basis and the effect on the rest of your portfolio matter more than the proxy calendar.
  • Compare the field. Our non-traded REIT tender offer census shows what other holders are being offered to leave funds.

If a large share of your wealth sits in BPRE, or you are deciding whether to sell at this discount, a second opinion on your own numbers may help.

FAQ

Filing alert · free

An email when Bluerock Private Real Estate Fund files with the SEC

An email the day Bluerock Private Real Estate Fund files something new, with the link to the document on the SEC site.

All figures are from SEC filings read on November 16, 2026: Saba Capital's Form DFAN14A of November 13, 2026 (accession 0000902664-26-004538; the four image pages, which we transcribed) and of September 25, 2026 (0000902664-26-003930); Saba's Schedule 13D/A No. 1 of August 27, 2026 (0001062993-26-004669); the fund's Forms 8-K of July 2, 2026 (0001398344-26-011663) and August 7, 2026 (0001398344-26-013771); the definitive proxy statement of June 30, 2026 (0002071844-26-000752); the semi-annual report for the six months to March 31, 2026 (0001398344-26-010444); and the Forms 4 and 4/A filed by the fund's insiders from September 18 to October 28, 2026 (accessions in the CSV). Prices for November 2, 2026 are quoted from Saba's filing, not from an exchange feed. Court records are not part of this page.

Affiliate Disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This does not affect our ratings. Learn more.